Evidence map›Paper›PMID 42416176›Full record

ArticleAlzheimer's & dementia (New York, N. Y.)

Association of

Dong-Ju Kim, Yong-Chan Kim, Byung-Hoon Jeong

Abstract read
In one paragraph

Article in Alzheimer's & dementia (New York, N. Y.). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Dong-Ju KimKorea Zoonosis Research Institute Jeonbuk National University Iksan Republic of Korea.
Yong-Chan KimSchool of Life Sciences and Biotechnology Gyeongkuk National University Andong Republic of Korea.
Byung-Hoon JeongKorea Zoonosis Research Institute Jeonbuk National University Iksan Republic of Korea.ORCID https://orcid.org/0000-0002-4525-9994

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionSphingosine kinase 1 (

methodsWe analyzed genotype and allele frequencies of polymorphisms in the

resultsAmong the identified SNPs, the genotype distribution of rs2247856 showed a significant association with AD. Haplotype analysis revealed that haplotype 3 (CAGTACGG) was significantly more frequent in patients with AD than in controls. Profiler of Multi-Omics Data (PROMO) analysis suggested that the rs2247856 A allele disrupts the activating transcription factor 3 transcription factor binding site. Luciferase assays demonstrated significantly reduced promoter activity in constructs containing the A allele compared to the G allele ( DISCUSSION: Our findings identify rs2247856 as a functional regulatory SNP in the

Indexed as

Alzheimer's diseasepolymorphismrs2247856 single nucleotide polymorphismsphingosine kinase 1susceptibilitytranscription efficiency

Identifiers

PMID42416176
PMCPMC13337528

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.